Instem Unveils Innovative Cloud Solution for Pathology Management

Innovative Pathology Module for Efficient Research

Instem has recently introduced its groundbreaking Non-GLP Pathology Module, a significant enhancement for its renowned Provantis platform. This innovative module is designed to improve the quality and efficiency of in vivo preclinical study management. By leveraging cutting-edge cloud technology, it simplifies the workflow for pathologists, which has become essential for modern research practices.

Streamlining Workflows with Cloud Technology

The new Non-GLP Pathology Module offers a sophisticated yet user-friendly interface that replaces outdated systems such as electronic spreadsheets and paper-based processes. This transition not only enhances data accuracy but also reduces task completion times significantly. With continuous updates and seamless integration features, users can expect a progressive solution that aids in managing complex data requirements effectively.

Enhanced User Experience

Beth Hazell, Chief Product Officer at Instem, emphasizes that the module aligns perfectly with the needs of customers, delivering extraordinary time savings and process improvements. It is tailored to help pathology teams across various sectors, ensuring they have the tools necessary for immediate and long-term success.

Integration with Provantis Ecosystem

One of the module's standout features is its ability to integrate flawlessly with the existing Provantis ecosystem. This integration provides comprehensive support across several essential components, including protocol definition, necropsy procedures, and comprehensive reporting capabilities, making it easier than ever for teams to manage data without disrupting their workflow.

Future-Ready Solutions

According to Vik Krishnan, CEO of Instem, the introduction of this module marks an important step towards modernizing non-GLP preclinical workflows. It highlights Instem's commitment to providing innovative solutions that enable researchers to discover new potential treatments while accelerating their research activities. The company remains focused on advancing these key R&D programs, setting the stage for future developments.

Accessibility and Further Information

This new module is now available alongside the existing GLP-compliant Pathology module, making it an essential addition to the Provantis platform. Users interested in leveraging the full advantages of this new feature can explore additional details through Instem’s official channels.

About Instem

Instem is recognized as a leader in SaaS platform development, specifically geared towards study management, regulatory submissions, and clinical trial analytics. They have a diverse range of applications that meet the growing demands of the life sciences and healthcare sectors worldwide. Founded in 1969 in the United Kingdom, Instem has built a robust international presence across regions such as North America, EMEA, and APAC.

The company prides itself on localized support and a commitment to helping their clients achieve data-driven decision-making, ultimately leading to the creation of safer and more effective products. With a focus on continual improvement and innovation, Instem's mission is to empower researchers to drive impactful change in their fields.

Frequently Asked Questions

What is the Non-GLP Pathology Module?

The Non-GLP Pathology Module is a new cloud-hosted tool introduced by Instem for managing pathology workflows within the Provantis platform, aimed at improving efficiency and data accuracy.

How does the module benefit pathologists?

This module helps pathologists move away from outdated tools, offering enhanced data accuracy, reduced task completion times, and cost efficiency through streamlined processes.

Is the module integrated with other Provantis features?

Yes, it integrates seamlessly with Provantis, supporting protocol definition, necropsy, and reporting, facilitating a more efficient workflow.

Who can use the Non-GLP Pathology Module?

The module is designed for various users in the life sciences field, especially pathologists engaged in preclinical research.

What is the vision of Instem with this launch?

Instem aims to modernize non-GLP preclinical workflows and support researchers in discovering potential treatments while accelerating their research activities.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.